“2025 is a landmark launch year for Bayer Pharmaceuticals, and we are pulling out all stops to drive the power of our pipeline,” said Stefan Oelrich, Member of the Board of ...

Bayer on April 1 showcased significant advancements in its pharmaceutical growth strategy and pipeline at its annual Pharma Media Day. As part of the ongoing transformation of its pharmaceutical ...

Bayer is lobbying U.S. states to adjust their regulations in the battle to control costly litigation targeting its herbicide ...

At the other end of the table, the worst performers were Astellas (+11), Eli Lilly (+21) and Teva Pharma (+28). "The likes of Bayer, Gilead and Sanofi are miles ahead in their EDI scorings ...

The National Pharmaceutical Pricing Authority (NPPA) has directed Bayer Zydus Pharma, a joint venture between Bayer and Zydus Lifesciences, to continue production and sales of various strengths and ...

FRANKFURT, March 26 (Reuters) - Bayer (BAYGn.DE), opens new tab said on Wednesday it struck a global licence agreement for an experimental oral cancer drug for targeted therapies with China's Puhe ...

"This is another significant milestone for Bayer Pharmaceuticals in China and further strengthens our strategic presence in Beijing," said Sebastian Guth, chief operating officer of Bayer ...

2024 annual results showed a 2.2% sales decline, with only free cash flow improving significantly; Pharmaceuticals saw slight growth, while Crop Science and Consumer Health declined. Bayer's 2025 ...

Dr. Marijn Dekkers, Bayer chief executive, 2010-2016 However, before we get into the history of this German pharmaceutical company ... own Bayer Cross corporate logo. This was under the leadership ...

Bernstein analyst Florent Cespedes maintained a Hold rating on Bayer (0P6S – Research Report) today and set a price target of €30.00. The company’s shares closed yesterday at €20.63.

Bayer (BAYRY) was ordered by a jury in Georgia, US to pay approximately $2.1B to a plaintiff claiming its Roundup weedkiller caused cancer, Tim Loh of Bloomberg reports. The verdict includes $65M ...